Lek Pharmaceuticals d.d. Email Format
Pharmaceutical ManufacturingSlovenia1001-5000 Employees
Lek, a Sandoz company, is the first and oldest pharmaceutical company in Slovenia, with nearly 80 years of tradition. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We develop, manufacture and market effective, safe, and high-quality generic pharmaceuticals, biosimilar medicines and active pharmaceutical ingredients for patients around the world, supplying nearly 60 markets. We are the largest provider of biosimilar medicines and the second largest company on generics market in Slovenia. ๐๐ฒ๐ด๐ฎ๐น ๐ฒ๐ป๐๐ถ๐๐ถ๐ฒ๐: โบ๏ธ Lek d.d., Verovลกkova ulica 57, 1526 Ljubljana โบ๏ธ Sandoz d.d., Verovลกkova ulica 57, 1526 Ljubljana ๐น In Slovenia, we generate approximately 2.2 percent of the national GDP. Each year, we invest over โฌ100 million in development. ๐น We are committed to investing in the growth, education, and training of our associates. For the sixth consecutive year, we have been recognized as the most reputable employer in Slovenia and, with more than 3,700 associates, we are the countryโs fourth-largest employer. ๐น We have been committed to co-creating the Slovenian research and educational ecosystem, contributing to progress in medicine and healthcare on a global scale. ๐๐ผ๐บ๐ฝ๐ฎ๐ป๐ ๐ฐ๐๐น๐๐๐ฟ๐ฒ ๐ฎ๐ป๐ฑ ๐๐ฎ๐น๐๐ฒ๐ We believe that every success begins with a team of motivated and engaged individuals. That is why we follow the Sandoz people strategy, which encourages our associates to develop and realize their full potential. We are creating an empowered, curious, and inspiring culture built on integrity and respect. We provide a safe and inclusive working environment where everyone feels accepted in their diversity. Follow us to see how we are #PioneeringAccess to affordable medicines for millions of patients around the world. ๐๐ผ๐บ๐บ๐๐ป๐ถ๐๐ ๐ด๐๐ถ๐ฑ๐ฒ๐น๐ถ๐ป๐ฒ๐: https://bit.ly/smernice-za-uporabo-druzbenih-medijev https://bit.ly/social-media-communitiy-guidelines